EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

HIV-1 Tropism Test Evaluation: Assessment and Clinical Implications

Stefania Chiappetta, Manuela Pogliaghi, Marco Ripa, Adriano Lazzarin, Giuseppe Tambussi, Silvia Nozza

ISRN Virology · 2014

DOI: 10.1155/2014/263793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Virology, 2014. Verfasst von Stefania Chiappetta und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CCR5 and CXCR4 chemokines receptors are critical coreceptors for the binding of HIV to specific host cells. Guidelines recommend its assessment in case of virological failure or before prescription of CCR5 inhibitors. Strategies to assess viral tropism may be divided into phenotypic and genotypic assays; registrative trials of CCR5 inhibitors used phenotypic assay, but recently genotypic ones have been used in clinical practice. The presence of CXCR4 is increasing in naïve patients, with both acute and chronic HIV-1 infections; this coreceptor usage is associated with CD4 depletion. The assessment of viral tropism should be considered in every stage of HIV-1 infection.

Zitieren

APA

Chiappetta, S., Pogliaghi, M., Ripa, M., Lazzarin, A., Tambussi, G., & Nozza, S. (2014). HIV-1 Tropism Test Evaluation: Assessment and Clinical Implications. ISRN Virology. https://doi.org/10.1155/2014/263793

Vancouver

Chiappetta S, Pogliaghi M, Ripa M, Lazzarin A, Tambussi G, Nozza S. HIV-1 Tropism Test Evaluation: Assessment and Clinical Implications. ISRN Virology. 2014. doi:10.1155/2014/263793

BibTeX
@article{Chiappetta2014,
  author = {Chiappetta, Stefania and Pogliaghi, Manuela and Ripa, Marco and Lazzarin, Adriano and Tambussi, Giuseppe and Nozza, Silvia},
  title = {HIV-1 Tropism Test Evaluation: Assessment and Clinical Implications},
  journal = {ISRN Virology},
  year = {2014},
  doi = {10.1155/2014/263793}
}
Kostenlos starten →